Molecular Profiles Strengthens Pharmaceutical IP Services With Prestigious Addition To Scientific Panel, UK

Main Category: Pharma Industry / Biotech Industry
Article Date: 21 Nov 2007 - 11:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Molecular Profiles, a global leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide, announces the expansion of its Scientific Panel with the appointment of industry guru Professor Lisbeth Illum. The Scientific Panel complements the intellectual property, patent litigation support and contract research services already offered by Molecular Profiles to the pharmaceutical and biomedical industries.

Pharmaceutical patent infringement is a common issue affecting the industry and expert opinion is often required in patent disputes. Molecular Profiles is experienced in the provision of technical support for such issues, and its unique Scientific Panel brings additional academic and industry expertise. With a proven reputation for integrity, confidentiality and scientific excellence, the Molecular Profiles Scientific Panel provides expertise across the complete pharmaceutical lifecycle.

The Scientific Panel originally consisted of Molecular Profiles' founders from the School of Pharmacy at the University of Nottingham, Professors Martyn Davies, Saul Tendler, Clive Roberts and Dr. Philip Williams. In late 2005 the Panel was expanded to incorporate additional industry and academic experts in order to provide a greater breadth of knowledge and experience to the existing range of Molecular Profiles services. With the recent addition of Professor Lisbeth Illum, the panel combines more than 300 years of experience and strengthens Molecular Profiles' services for R&D and patent litigation.

Professor Lisbeth Illum has over 25 years' experience in the pharmaceutical industry, and has held a variety of academic, editorial and professional positions including consulting to several multinational pharmaceutical companies. Among the top 100 most-cited scientists on pharmacology, Illum has published more than 300 scientific papers and has filed nearly 50 patents on novel drug delivery systems. Professor Illum will also be the President of the Controlled Release Society in 2008.

"We are delighted to announce Professor Illum's appointment to our Scientific Panel", comments Dr. Nikin Patel, CEO, Molecular Profiles. "Lisbeth's experience aligns extremely well with our world-leading contract research and testing services."

More information about Molecular Profiles' award-winning services is available at http://www.molprofiles.co.uk.

About Molecular Profiles

Molecular Profiles is a leader in the provision of innovative contract research services to the pharmaceutical, biopharmaceutical and biomedical sectors worldwide. The company is a recipient of a Queen's Award for Enterprise in the Continuous Innovation and Development category. The award saw the company and its complete range of services recognised as one of the UK's most innovative during 2007. The services include nanoscreening technology for predicting the ease of development of a new medicine, a deformulation service for identifying problems with a product down to the nanoscale, and advanced imaging for viewing and optimising the internal structure of products.

http://www.molprofiles.co.uk